Argus Research analyst Gary Hovis downgrades Atmos Energy (NYSE:ATO) from Buy to Hold.
BTIG Upgrades Galera Therapeutics to Buy, Announces $15 Price Target
BTIG analyst Robert Hazlett upgrades Galera Therapeutics (NASDAQ:GRTX) from Neutral to Buy and announces $15 price target.